Rapid Micro Biosystems, Inc. is a life sciences technology company. The company is headquartered in Lexington, Massachusetts and currently employs 171 full-time employees. The company went IPO on 2021-07-15. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. The company offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Mr. Robert Spignesi is the President of Rapid Micro Biosystems, Inc, joining the firm since 2014.
What is the price performance of RPID stock?
The current price of RPID is $2.01, it has increased 2.55% in the last trading day.
What are the primary business themes or industries for Rapid Micro Biosystems, Inc?
Rapid Micro Biosystems, Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Rapid Micro Biosystems, Inc market cap?
Rapid Micro Biosystems, Inc's current market cap is $91.9M
Is Rapid Micro Biosystems, Inc a buy, sell, or hold?
According to wall street analysts, 4 analysts have made analyst ratings for Rapid Micro Biosystems, Inc, including 3 strong buy, 6 buy, 1 hold, 0 sell, and 3 strong sell